Join us on Thursday, 1st February 2024, for the inaugural Future of Advanced Therapies event, illuminating the trailblazing landscape of R&D in life sciences within the UK.

This free event aims to help drive engagement at the forefront of medical innovation, bringing together the UK’s leading researchers who are creating next generation medicines, devices, tools and associated technologies. This is an extremely fast-moving sector that will change the face of healthcare and significantly impact patients, clinical trials, and the regulatory system.

A dynamic line-up of speakers will be covering key aspects of how xRNA, Nucleic acids, Cell and Gene Therapies can be brought to bear to tackle the most challenging diseases, and our main panel, including the CEO of Bayer UK, UK Medical Director of Moderna, Vice President Global Regulatory Affairs at BioNTech, CEO of Barinthus Biotherapeutics and Executive Director of NATA, will offer unique insights into the future of advanced therapies.

This one-day event is hosted at Harwell Campus’ new cutting-edge conference centre, and curated by the UKRI-STFC Harwell and North west of England's Health Clusters.

Reserve your place now and register to join us for a captivating and forward-thinking event that explores transformative technologies.

The Future of Advanced Therapies